ReviewACS materials Au2025
Emerging 4D Fabrication of Tubular Structures and Clinical Challenges: Critical Perspective.
Review in ACS materials Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Scaffolds to Complex Systems: Functional Biomaterials in Regenerative Medicine.Journal of functional biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The burgeoning field of 4D fabrication holds transformative potential in fabricating dynamic, tubular structures such as artificial vascular grafts, stents, and nerve conduits. These are critical for cardiovascular, respiratory, and neurological applications. Traditional 3D printing, despite its advances, remains constrained by the static nature of its structures, often resulting in challenges such as improper vascular integration, restricted endothelialisation in small-diameter grafts, and complex surgical deployment requirements. This perspective delves into the novel integration of stimuli-responsive smart materials that imbue printed structures with the ability to morph, repair, and adapt to specific environmental stimuli, facilitating a more biocompatible and physiologically relevant interface. Highlighting recent breakthroughs in vascular graft fabrication, we discuss the strategic use of multimaterial printing to achieve endothelial compatibility and structural fidelity. Moreover, advancements in bifurcated stents and multichannel nerve conduits underscore the role of self-assembling and self-folding mechanisms in addressing anatomical and biomechanical complexities inherent in regenerative medicine. However, the translational trajectory of 4D bioprinting is impeded by persistent issues like material scalability, stimulus precision control, mechanical stability, and stringent biocompatibility standards. Future research should prioritize the refinement of multifunctional biomaterials and the development of composite, stimuli-responsive scaffolds equipped with biosensor functionalities to better mimic the dynamic biomechanics of native tissues. This review provides an in-depth analysis of these challenges and explores pathways toward the clinical adoption of 4D-printed, biomimetic tubular structures, aiming to bridge the gap between experimental innovation and clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.